 | • レポートコード：QYR2104Z3050 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥565,500 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥848,250 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,131,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、免疫細胞療法のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（キメラ抗原受容体（CAR）T細胞療法、ナチュラルキラー（NK）細胞療法、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・免疫細胞療法の市場動向 ・企業の競争状況、市場シェア ・免疫細胞療法の種類別市場規模（キメラ抗原受容体（CAR）T細胞療法、ナチュラルキラー（NK）細胞療法、その他） ・免疫細胞療法の用途別市場規模（病院、クリニック、その他） ・免疫細胞療法の北米市場規模2016-2027（アメリカ、カナダ） ・免疫細胞療法のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・免疫細胞療法のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・免疫細胞療法の中南米市場規模2016-2027（メキシコ、ブラジル） ・免疫細胞療法の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Gilead Sciences、Novartis） ・結論 |
Immune therapy is a new class of cancer treatment designed to boost or enhance the body’s immune system to more efficiently target and destroy cancerous cells. Many experts believe that immunotherapy represents the most promising new cancer treatment since the development of chemotherapy.
Market Analysis and Insights: Global Immunocell Therapy Market
The global Immunocell Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Immunocell Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Immunocell Therapy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Immunocell Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Immunocell Therapy market.
Global Immunocell Therapy Scope and Market Size
Immunocell Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Immunocell Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Chimeric Antigen Receptor (CAR) T Cell Therapy
Natural Killer (NK) Cell Therapy
Others
Segment by Application
Hospitals
Clinics
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
レポート目次1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immunocell Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Chimeric Antigen Receptor (CAR) T Cell Therapy
1.2.3 Natural Killer (NK) Cell Therapy
1.2.4 Others
1.3 Market by Application
1.3.1 Global Immunocell Therapy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Immunocell Therapy Market Perspective (2016-2027)
2.2 Immunocell Therapy Growth Trends by Regions
2.2.1 Immunocell Therapy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Immunocell Therapy Historic Market Share by Regions (2016-2021)
2.2.3 Immunocell Therapy Forecasted Market Size by Regions (2022-2027)
2.3 Immunocell Therapy Industry Dynamic
2.3.1 Immunocell Therapy Market Trends
2.3.2 Immunocell Therapy Market Drivers
2.3.3 Immunocell Therapy Market Challenges
2.3.4 Immunocell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Immunocell Therapy Players by Revenue
3.1.1 Global Top Immunocell Therapy Players by Revenue (2016-2021)
3.1.2 Global Immunocell Therapy Revenue Market Share by Players (2016-2021)
3.2 Global Immunocell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Immunocell Therapy Revenue
3.4 Global Immunocell Therapy Market Concentration Ratio
3.4.1 Global Immunocell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immunocell Therapy Revenue in 2020
3.5 Immunocell Therapy Key Players Head office and Area Served
3.6 Key Players Immunocell Therapy Product Solution and Service
3.7 Date of Enter into Immunocell Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Immunocell Therapy Breakdown Data by Type
4.1 Global Immunocell Therapy Historic Market Size by Type (2016-2021)
4.2 Global Immunocell Therapy Forecasted Market Size by Type (2022-2027)
5 Immunocell Therapy Breakdown Data by Application
5.1 Global Immunocell Therapy Historic Market Size by Application (2016-2021)
5.2 Global Immunocell Therapy Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Immunocell Therapy Market Size (2016-2027)
6.2 North America Immunocell Therapy Market Size by Type
6.2.1 North America Immunocell Therapy Market Size by Type (2016-2021)
6.2.2 North America Immunocell Therapy Market Size by Type (2022-2027)
6.2.3 North America Immunocell Therapy Market Size by Type (2016-2027)
6.3 North America Immunocell Therapy Market Size by Application
6.3.1 North America Immunocell Therapy Market Size by Application (2016-2021)
6.3.2 North America Immunocell Therapy Market Size by Application (2022-2027)
6.3.3 North America Immunocell Therapy Market Size by Application (2016-2027)
6.4 North America Immunocell Therapy Market Size by Country
6.4.1 North America Immunocell Therapy Market Size by Country (2016-2021)
6.4.2 North America Immunocell Therapy Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Immunocell Therapy Market Size (2016-2027)
7.2 Europe Immunocell Therapy Market Size by Type
7.2.1 Europe Immunocell Therapy Market Size by Type (2016-2021)
7.2.2 Europe Immunocell Therapy Market Size by Type (2022-2027)
7.2.3 Europe Immunocell Therapy Market Size by Type (2016-2027)
7.3 Europe Immunocell Therapy Market Size by Application
7.3.1 Europe Immunocell Therapy Market Size by Application (2016-2021)
7.3.2 Europe Immunocell Therapy Market Size by Application (2022-2027)
7.3.3 Europe Immunocell Therapy Market Size by Application (2016-2027)
7.4 Europe Immunocell Therapy Market Size by Country
7.4.1 Europe Immunocell Therapy Market Size by Country (2016-2021)
7.4.2 Europe Immunocell Therapy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Immunocell Therapy Market Size (2016-2027)
8.2 Asia-Pacific Immunocell Therapy Market Size by Type
8.2.1 Asia-Pacific Immunocell Therapy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Immunocell Therapy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Immunocell Therapy Market Size by Type (2016-2027)
8.3 Asia-Pacific Immunocell Therapy Market Size by Application
8.3.1 Asia-Pacific Immunocell Therapy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Immunocell Therapy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Immunocell Therapy Market Size by Application (2016-2027)
8.4 Asia-Pacific Immunocell Therapy Market Size by Region
8.4.1 Asia-Pacific Immunocell Therapy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Immunocell Therapy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Immunocell Therapy Market Size (2016-2027)
9.2 Latin America Immunocell Therapy Market Size by Type
9.2.1 Latin America Immunocell Therapy Market Size by Type (2016-2021)
9.2.2 Latin America Immunocell Therapy Market Size by Type (2022-2027)
9.2.3 Latin America Immunocell Therapy Market Size by Type (2016-2027)
9.3 Latin America Immunocell Therapy Market Size by Application
9.3.1 Latin America Immunocell Therapy Market Size by Application (2016-2021)
9.3.2 Latin America Immunocell Therapy Market Size by Application (2022-2027)
9.3.3 Latin America Immunocell Therapy Market Size by Application (2016-2027)
9.4 Latin America Immunocell Therapy Market Size by Country
9.4.1 Latin America Immunocell Therapy Market Size by Country (2016-2021)
9.4.2 Latin America Immunocell Therapy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Immunocell Therapy Market Size (2016-2027)
10.2 Middle East & Africa Immunocell Therapy Market Size by Type
10.2.1 Middle East & Africa Immunocell Therapy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Immunocell Therapy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Immunocell Therapy Market Size by Type (2016-2027)
10.3 Middle East & Africa Immunocell Therapy Market Size by Application
10.3.1 Middle East & Africa Immunocell Therapy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Immunocell Therapy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Immunocell Therapy Market Size by Application (2016-2027)
10.4 Middle East & Africa Immunocell Therapy Market Size by Country
10.4.1 Middle East & Africa Immunocell Therapy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Immunocell Therapy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Gilead Sciences
11.1.1 Gilead Sciences Company Details
11.1.2 Gilead Sciences Business Overview
11.1.3 Gilead Sciences Immunocell Therapy Introduction
11.1.4 Gilead Sciences Revenue in Immunocell Therapy Business (2016-2021)
11.1.5 Gilead Sciences Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Immunocell Therapy Introduction
11.2.4 Novartis Revenue in Immunocell Therapy Business (2016-2021)
11.2.5 Novartis Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Immunocell Therapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Chimeric Antigen Receptor (CAR) T Cell Therapy
Table 3. Key Players of Natural Killer (NK) Cell Therapy
Table 4. Key Players of Others
Table 5. Global Immunocell Therapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Immunocell Therapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Immunocell Therapy Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Immunocell Therapy Market Share by Regions (2016-2021)
Table 9. Global Immunocell Therapy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Immunocell Therapy Market Share by Regions (2022-2027)
Table 11. Immunocell Therapy Market Trends
Table 12. Immunocell Therapy Market Drivers
Table 13. Immunocell Therapy Market Challenges
Table 14. Immunocell Therapy Market Restraints
Table 15. Global Immunocell Therapy Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Immunocell Therapy Market Share by Players (2016-2021)
Table 17. Global Top Immunocell Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immunocell Therapy as of 2020)
Table 18. Ranking of Global Top Immunocell Therapy Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Immunocell Therapy Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Immunocell Therapy Product Solution and Service
Table 22. Date of Enter into Immunocell Therapy Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Immunocell Therapy Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Immunocell Therapy Revenue Market Share by Type (2016-2021)
Table 26. Global Immunocell Therapy Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Immunocell Therapy Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Immunocell Therapy Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Immunocell Therapy Revenue Market Share by Application (2016-2021)
Table 30. Global Immunocell Therapy Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Immunocell Therapy Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Immunocell Therapy Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Immunocell Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Immunocell Therapy Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Immunocell Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Immunocell Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Immunocell Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Immunocell Therapy Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Immunocell Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Immunocell Therapy Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Immunocell Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Immunocell Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Immunocell Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Immunocell Therapy Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Immunocell Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Immunocell Therapy Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Immunocell Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Immunocell Therapy Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Immunocell Therapy Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Immunocell Therapy Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Immunocell Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Immunocell Therapy Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Immunocell Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Immunocell Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Immunocell Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Immunocell Therapy Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Immunocell Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Immunocell Therapy Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Immunocell Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Immunocell Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Immunocell Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 62. Gilead Sciences Company Details
Table 63. Gilead Sciences Business Overview
Table 64. Gilead Sciences Immunocell Therapy Product
Table 65. Gilead Sciences Revenue in Immunocell Therapy Business (2016-2021) & (US$ Million)
Table 66. Gilead Sciences Recent Development
Table 67. Novartis Company Details
Table 68. Novartis Business Overview
Table 69. Novartis Immunocell Therapy Product
Table 70. Novartis Revenue in Immunocell Therapy Business (2016-2021) & (US$ Million)
Table 71. Novartis Recent Development
Table 72. Research Programs/Design for This Report
Table 73. Key Data Information from Secondary Sources
Table 74. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Immunocell Therapy Market Share by Type: 2020 VS 2027
Figure 2. Chimeric Antigen Receptor (CAR) T Cell Therapy Features
Figure 3. Natural Killer (NK) Cell Therapy Features
Figure 4. Others Features
Figure 5. Global Immunocell Therapy Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Others Case Studies
Figure 9. Immunocell Therapy Report Years Considered
Figure 10. Global Immunocell Therapy Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Immunocell Therapy Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Immunocell Therapy Market Share by Regions: 2020 VS 2027
Figure 13. Global Immunocell Therapy Market Share by Regions (2022-2027)
Figure 14. Global Immunocell Therapy Market Share by Players in 2020
Figure 15. Global Top Immunocell Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immunocell Therapy as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Immunocell Therapy Revenue in 2020
Figure 17. Global Immunocell Therapy Revenue Market Share by Type (2016-2021)
Figure 18. Global Immunocell Therapy Revenue Market Share by Type (2022-2027)
Figure 19. North America Immunocell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Immunocell Therapy Market Share by Type (2016-2027)
Figure 21. North America Immunocell Therapy Market Share by Application (2016-2027)
Figure 22. North America Immunocell Therapy Market Share by Country (2016-2027)
Figure 23. United States Immunocell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Immunocell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Immunocell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Immunocell Therapy Market Share by Type (2016-2027)
Figure 27. Europe Immunocell Therapy Market Share by Application (2016-2027)
Figure 28. Europe Immunocell Therapy Market Share by Country (2016-2027)
Figure 29. Germany Immunocell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Immunocell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Immunocell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Immunocell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Immunocell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Immunocell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Immunocell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Immunocell Therapy Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Immunocell Therapy Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Immunocell Therapy Market Share by Region (2016-2027)
Figure 39. China Immunocell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Immunocell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Immunocell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Immunocell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Immunocell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Immunocell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Immunocell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Immunocell Therapy Market Share by Type (2016-2027)
Figure 47. Latin America Immunocell Therapy Market Share by Application (2016-2027)
Figure 48. Latin America Immunocell Therapy Market Share by Country (2016-2027)
Figure 49. Mexico Immunocell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Immunocell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Immunocell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Immunocell Therapy Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Immunocell Therapy Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Immunocell Therapy Market Share by Country (2016-2027)
Figure 55. Turkey Immunocell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Immunocell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Immunocell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Gilead Sciences Revenue Growth Rate in Immunocell Therapy Business (2016-2021)
Figure 59. Novartis Revenue Growth Rate in Immunocell Therapy Business (2016-2021)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
世界の変形性関節症幹細胞治療市場規模・現状・予測（2021年-2027年） Osteoarthritis is one of the chronic conditions for joints which results in the breakdown and eventual loss of the cartilage of one or more joints. This can affect joints including hips, lower back, neck, small joints of the fingers, and the base of the thumb and big toe. The expected growth is beca…- 世界の多発性骨髄腫用CART細胞療法市場規模・現状・予測（2021年-2027年） CARs are also known as chimeric immunoreceptors, chimeric T-cell receptors, artificial T-cell receptors or CAR T. they are used as an individual's own cells and re-engineers them to fight cancer. Though the market has witnessed several positive results of the clinical trial in the recent years, it i…
- 世界の多発性骨髄腫用CART細胞療法市場規模・現状・予測（2021年-2027年） CARs are also known as chimeric immunoreceptors, chimeric T-cell receptors, artificial T-cell receptors or CAR T. they are used as an individual's own cells and re-engineers them to fight cancer. Though the market has witnessed several positive results of the clinical trial in the recent years, it i…
- 世界のがん幹細胞（CSC）治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Cancer Stem Cell Therapy Market The global Cancer Stem Cell Therapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the …
- 世界の関節リウマチ幹細胞治療市場規模・現状・予測（2021年-2027年） Rheumatoid arthritis stem cell therapy has been demonstrated to induce profound healing activity, halt arthritic conditions, and in many cases, reverse and regenerate joint tissue. Today, bone marrow transplant, adipose or fat-derived stem cells, and allogeneic mesenchymal stem cells (human umbilica…